文章摘要
殷芳,郭致平.新辅助化疗对胃癌术后并发症的预防作用[J].安徽医药,2020,24(11):2267-2272.
新辅助化疗对胃癌术后并发症的预防作用
Preventive effect of neoadjuvant chemotherapy on postoperative complications of gastric cancer
  
DOI:10.3969/j.issn.1009?6469.2020.11.039
中文关键词: 胃肿瘤  化学疗法,辅助  手术后并发症  炎症趋化因子类
英文关键词: Stomach neoplasms  Chemotherapy,adjuvant  Postoperative complications  Chemokines
基金项目:
作者单位
殷芳 云南省第三人民医院消化内科云南昆明 650000 
郭致平 云南省第三人民医院消化内科云南昆明 650000 
摘要点击次数: 2241
全文下载次数: 703
中文摘要:
      目的探讨新辅助化疗能否预防胃癌根治术后并发症导致的不良预后。方法回顾性分析 2009年 1月至 2016年 12月云南省第三人民医院新辅助化疗联合胃癌根治术病人 157例及直接行胃癌根治术病人 139例。比较新辅助化疗联合胃癌根治术组中有并发症和无并发症病人的总体生存率和无复发生存率。结果在直接行胃癌根治术的病人中,并发症的发生率为 48.20%高于联合新辅助化疗病人的 35.03%(χ2=5.278,P=0.022)。 157例新辅助化疗联合胃癌根治术病人中有 55例(35%)出现 2级以上并发症。在有并发症的病人中, 3年总体生存率、 3年无复发生存率分别为 64.61%和 43.55%,而对于无并发症病人, 3年总体生存率、 3年无复发生存率分别为 68.26%和 48.78%,有并发症病人与无并发症病人的预后差异无统计学意义。在多因素分析中,肿瘤退缩分级与总体存活率和无复发生存率差独立相关(P=0.030)。结论新辅助化疗可减少胃癌根治术病人术后并发症的发生率,且可减少胃癌根治术后并发症所导致的不良预后;肿瘤新辅助治疗后的退缩反应对病人的预后有显著影响,能指导术后辅助治疗方案的选择。
英文摘要:
      Objective To investigate whether neoadjuvant chemotherapy can prevent adverse prognosis caused by complications af?ter radical gastrectomy for gastric cancer.Methods The clinical data of 157 cases of neoadjuvant chemotherapy combined withradical gastrectomy and 139 cases of direct radical gastrectomy from January 2009 to December 2016 were retrospectively analyzed.To compare the overall survival rate and recurrence?free survival rate of patients with complications and without complications inneoadjuvant chemotherapy combined with radical gastrectomy for gastric cancer.Results The incidence of complications in pa?tients undergoing radical gastrectomy was higher than that in patients receiving neoadjuvant chemotherapy(48.20% vs. 35.03%, χ2=5.278,P=0.022).Among 157 cases of neoadjuvant chemotherapy combined with radical gastrectomy,55 cases(35%) had grade 2 or more complications.In patients with complications,the 3?year overall survival rate and 3?year recurrence?free survival rate were 64.605% and 43.552%,respectively.For patients without complications,the 3?year overall survival rate and 3?year recur? rence?free survival rate were 68.255% and 48.770%,respectively.There was no significant difference in the prognosis between pa?tients with complications and patients without complications.In multivariate analysis,regression grade was independently correlated with overall survival and poor relapse?free survival(P=0.030).Conclusion This study shows that neoadjuvant chemotherapy canreduce the incidence of complications after radical gastrectomy and the adverse prognosis caused by complications after radical gas?trectomy.The retraction reaction after neoadjuvant therapy has a significant impact on the prognosis of patients,and can guide the choice of adjuvant therapy after radical gastrectomy.
查看全文   查看/发表评论  下载PDF阅读器
关闭

分享按钮